239 related articles for article (PubMed ID: 35378709)
1. KRAS Addiction Promotes Cancer Cell Adaptation in Harsh Microenvironment Through Macropinocytosis.
Seguin L
Subcell Biochem; 2022; 98():189-204. PubMed ID: 35378709
[TBL] [Abstract][Full Text] [Related]
2. KRAS
Hobbs GA; Der CJ
Subcell Biochem; 2022; 98():205-221. PubMed ID: 35378710
[TBL] [Abstract][Full Text] [Related]
3. Exploiting macropinocytosis for drug delivery into KRAS mutant cancer.
Liu H; Qian F
Theranostics; 2022; 12(3):1321-1332. PubMed ID: 35154489
[TBL] [Abstract][Full Text] [Related]
4. Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer.
Hanada K; Kawada K; Nishikawa G; Toda K; Maekawa H; Nishikawa Y; Masui H; Hirata W; Okamoto M; Kiyasu Y; Honma S; Ogawa R; Mizuno R; Itatani Y; Miyoshi H; Sasazuki T; Shirasawa S; Taketo MM; Obama K; Sakai Y
Cancer Lett; 2021 Dec; 522():129-141. PubMed ID: 34543685
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer.
Xiong X; Rao G; Roy RV; Zhang Y; Means N; Dey A; Tsaliki M; Saha S; Bhattacharyya S; Dhar Dwivedi SK; Rao CV; McCormick DJ; Dhanasekaran D; Ding K; Gillies E; Zhang M; Yang D; Bhattacharya R; Mukherjee P
FASEB J; 2020 Sep; 34(9):12024-12039. PubMed ID: 32692445
[TBL] [Abstract][Full Text] [Related]
6. Macropinocytosis and Cancer: From Tumor Stress to Signaling Pathways.
Lambies G; Commisso C
Subcell Biochem; 2022; 98():15-40. PubMed ID: 35378701
[TBL] [Abstract][Full Text] [Related]
7. Gold Nanoparticles Inhibit Macropinocytosis by Decreasing KRAS Activation.
Elechalawar CK; Rao G; Gulla SK; Patel MM; Frickenstein A; Means N; Roy RV; Tsiokas L; Asfa S; Panja P; Rao C; Wilhelm S; Bhattacharya R; Mukherjee P
ACS Nano; 2023 May; 17(10):9326-9337. PubMed ID: 37129853
[TBL] [Abstract][Full Text] [Related]
8. CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in
Lee DS; Han MW; Kang Y; Kim C; Lee S; Kim KP; Yoo C
Anticancer Res; 2024 May; 44(5):1939-1946. PubMed ID: 38677763
[TBL] [Abstract][Full Text] [Related]
9. Transcription Factor Eb Is Required for Macropinocytosis-Mediated Growth Recovery of Nutrient-Deprived Kras-Mutant Cells.
Jeong S; Byun JK; Cho SJ; Chin J; Lee IK; Choi YK; Park KG
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400219
[TBL] [Abstract][Full Text] [Related]
10. Metabolic functions of macropinocytosis.
Palm W
Philos Trans R Soc Lond B Biol Sci; 2019 Feb; 374(1765):20180285. PubMed ID: 30967008
[TBL] [Abstract][Full Text] [Related]
11. Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis.
Liu X; Ghosh D
Int J Nanomedicine; 2019; 14():6589-6600. PubMed ID: 31496700
[TBL] [Abstract][Full Text] [Related]
12. The pervasiveness of macropinocytosis in oncological malignancies.
Commisso C
Philos Trans R Soc Lond B Biol Sci; 2019 Feb; 374(1765):20180153. PubMed ID: 30967003
[TBL] [Abstract][Full Text] [Related]
13. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis.
Thu PM; Zheng ZG; Zhou YP; Wang YY; Zhang X; Jing D; Cheng HM; Li J; Li P; Xu X
Eur J Pharmacol; 2019 May; 850():23-34. PubMed ID: 30716311
[TBL] [Abstract][Full Text] [Related]
14. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
Yao W; Rose JL; Wang W; Seth S; Jiang H; Taguchi A; Liu J; Yan L; Kapoor A; Hou P; Chen Z; Wang Q; Nezi L; Xu Z; Yao J; Hu B; Pettazzoni PF; Ho IL; Feng N; Ramamoorthy V; Jiang S; Deng P; Ma GJ; Den P; Tan Z; Zhang SX; Wang H; Wang YA; Deem AK; Fleming JB; Carugo A; Heffernan TP; Maitra A; Viale A; Ying H; Hanash S; DePinho RA; Draetta GF
Nature; 2019 Apr; 568(7752):410-414. PubMed ID: 30918400
[TBL] [Abstract][Full Text] [Related]
15. Impact of Oncogenic Changes in p53 and KRAS on Macropinocytosis and Ferroptosis in Colon Cancer Cells and Anticancer Efficacy of Niclosamide with Differential Effects on These Two Processes.
Nguyen NT; Sennoune SR; Dharmalingam-Nandagopal G; Sivaprakasam S; Bhutia YD; Ganapathy V
Cells; 2024 May; 13(11):. PubMed ID: 38891084
[TBL] [Abstract][Full Text] [Related]
16. Targeting RAS mutants in malignancies: successes, failures, and reasons for hope.
Yang H; Zhou X; Fu D; Le C; Wang J; Zhou Q; Liu X; Yuan Y; Ding K; Xiao Q
Cancer Commun (Lond); 2023 Jan; 43(1):42-74. PubMed ID: 36316602
[TBL] [Abstract][Full Text] [Related]
17. Unravelling the Mechanism of TrkA-Induced Cell Death by Macropinocytosis in Medulloblastoma Daoy Cells.
Li C; MacDonald JI; Talebian A; Leuenberger J; Seah C; Pasternak SH; Michnick SW; Meakin SO
Mol Cell Biol; 2016 Oct; 36(20):2596-611. PubMed ID: 27503856
[TBL] [Abstract][Full Text] [Related]
18. Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer.
Recouvreux MV; Commisso C
Front Endocrinol (Lausanne); 2017; 8():261. PubMed ID: 29085336
[TBL] [Abstract][Full Text] [Related]
19. Exploiting cancer's drinking problem: regulation and therapeutic potential of macropinocytosis.
Puccini J; Badgley MA; Bar-Sagi D
Trends Cancer; 2022 Jan; 8(1):54-64. PubMed ID: 34649835
[TBL] [Abstract][Full Text] [Related]
20. Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer.
Yuan F; Sun M; Liu Z; Liu H; Kong W; Wang R; Qian F
Theranostics; 2022; 12(3):1061-1073. PubMed ID: 35154474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
